14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.94 $4.15 Thursday, 2nd May 2024 CLRB stock ended at $3.34. This is 5.70% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 4.89% from a day low at $3.25 to a day high of $3.41.
90 days $2.94 $4.45
52 weeks $1.33 $4.45

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
Aug 27, 2020 $1.23 $1.26 $1.18 $1.20 349 207
Aug 26, 2020 $1.20 $1.30 $1.20 $1.23 349 729
Aug 25, 2020 $1.20 $1.30 $1.16 $1.20 813 494
Aug 24, 2020 $1.18 $1.20 $1.12 $1.16 824 965
Aug 21, 2020 $1.20 $1.23 $1.17 $1.18 503 164
Aug 20, 2020 $1.29 $1.30 $1.20 $1.22 810 389
Aug 19, 2020 $1.37 $1.38 $1.29 $1.30 1 021 266
Aug 18, 2020 $1.41 $1.42 $1.35 $1.38 1 000 736
Aug 17, 2020 $1.52 $1.57 $1.34 $1.45 3 726 956
Aug 14, 2020 $1.39 $1.44 $1.35 $1.43 681 224
Aug 13, 2020 $1.35 $1.41 $1.34 $1.36 533 972
Aug 12, 2020 $1.35 $1.38 $1.30 $1.37 939 957
Aug 11, 2020 $1.42 $1.45 $1.38 $1.39 476 998
Aug 10, 2020 $1.42 $1.46 $1.39 $1.41 690 837
Aug 07, 2020 $1.40 $1.42 $1.38 $1.40 417 616
Aug 06, 2020 $1.42 $1.43 $1.38 $1.40 452 012
Aug 05, 2020 $1.45 $1.45 $1.39 $1.42 417 280
Aug 04, 2020 $1.46 $1.48 $1.39 $1.40 816 024
Aug 03, 2020 $1.54 $1.54 $1.46 $1.49 547 699
Jul 31, 2020 $1.72 $1.74 $1.48 $1.51 1 804 755
Jul 30, 2020 $1.51 $1.72 $1.47 $1.66 10 719 485
Jul 29, 2020 $1.39 $1.40 $1.28 $1.37 999 726
Jul 28, 2020 $1.42 $1.44 $1.38 $1.38 327 717
Jul 27, 2020 $1.44 $1.46 $1.39 $1.41 266 968
Jul 24, 2020 $1.40 $1.42 $1.36 $1.42 370 592
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT